Legal challenges put off label use of gender affirming care drugs in jeopardy
Pharmaceutical Technology
MARCH 16, 2023
Dr. Edmund Horowicz PhD, a lecturer in medical law and ethics at the University of Liverpool, counters discourse from those such as the Norwegian Healthcare Investigation Board UKOM , that characterises puberty blockers as “experimental” and untrustworthy due to their off-label prescription. But the funding is not there, he adds.
144 
Let's personalize your content